Publications by authors named "Colleen Callahan"

Claim this Profile
C
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy.
Regina M Myers, Amanda M DiNofia, Yimei Li, Caroline Diorio, Hongyan Liu, Colleen Callahan

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy.
Barbara D Friedes, Amanda M DiNofia, Emma Iannone, Yimei Li, Susan R Rheingold, Colleen Callahan

Blood Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia.
Regina M Myers, Kaitlin Devine, Yimei Li, Sophie Lawrence, Allison Barz Leahy, Colleen Callahan

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T cells for pediatric malignancies: Past, present, future and nursing implications.
Colleen Callahan, Lauren Haas, Laura Smith

Asia Pac J Oncol Nurs· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Step Toward Personalized Surgical Decision Making: Machine Learning Predicts 1 Versus Numerous Melanoma Lymph Node Metastases Using RNA-sequencing.
Max O Meneveau, Rick D Vavolizza, Anwaruddin Mohammad, Pankaj Kumar, Joseph T Manderfield, Colleen Callahan

Ann Surg· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.
Haley Newman, Yimei Li, Hongyan Liu, Regina M Myers, Vicky Tam, Colleen Callahan

Blood· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report.
Kevin Owen McNerney, Rebecca M Richards, Paibel Aguayo-Hiraldo, Friso G Calkoen, Julie-An Talano, Colleen Callahan

J Immunother Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.
Allison Barz Leahy, Kaitlin J Devine, Yimei Li, Hongyan Liu, Regina Myers, Colleen Callahan

Blood· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials.
Allison Barz Leahy, Haley Newman, Yimei Li, Hongyan Liu, Regina Myers, Colleen Callahan

Lancet Haematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia.
Regina M Myers, Yimei Li, Allison Barz Leahy, David M Barrett, David T Teachey, Colleen Callahan

J Clin Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial.
Stephan Kadauke, Regina M Myers, Yimei Li, Richard Aplenc, Diane Baniewicz, Colleen Callahan

J Clin Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events.
Marcela V Maus, Sara Alexander, Michael R Bishop, Jennifer N Brudno, Colleen Callahan

J Immunother Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous immunoglobulin replacement following CD19-specific chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia in pediatric patients.
Danielle E Arnold, Shannon L Maude, Colleen A Callahan, Amanda M DiNofia, Stephan A Grupp

Pediatr Blood Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia: A Randomized Clinical Trial.
Brian T Fisher, Theoklis Zaoutis, Christopher C Dvorak, Michael Nieder, Danielle Zerr, Colleen Callahan

JAMA· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Survivorship: Considerations Following CAR T-Cell Therapy.
Colleen Callahan, Amy Barry, Stephanie Fooks-Parker, Laura Smith, Diane Baniewicz

Clin J Oncol Nurs· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Immunotherapy: An Evidence-Based Overview and Implications for Practice.
Virginia Bayer, Beau Amaya, Diane Baniewicz, Colleen Callahan, Lisa Marsh

Clin J Oncol Nurs· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T-Cell Therapy: Pediatric Patients With Relapsed and Refractory Acute Lymphoblastic Leukemia
.
Colleen Callahan, Diane Baniewicz, Beth Ely

Clin J Oncol Nurs· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for High-Risk Neuroblastoma: Management of Side Effects and Complications.
Erin Armideo, Colleen Callahan, Lara Madonia

J Adv Pract Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy.
Vijay G Bhoj, Dimitrios Arhontoulis, Gerald Wertheim, James Capobianchi, Colleen A Callahan

Blood· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.
David T Teachey, Simon F Lacey, Pamela A Shaw, J Joseph Melenhorst, Shannon L Maude, Colleen Callahan

Cancer Discov· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma.
Stephan A Grupp, Eline Luning Prak, Jean Boyer, Kenyetta R McDonald, Suzanne Shusterman, Colleen Callahan

Clin Cancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FXTAS, SCA10, and SCA17 in American patients with movement disorders.
Ana I Seixas, Martin H Maurer, Mark Lin, Colleen Callahan, Alka Ahuja

Am J Med Genet A· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central line placement for the pediatric oncology patient: a model of advanced practice nurse collaboration.
Colleen Callahan, Hope De La Cruz

J Pediatr Oncol Nurs· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis